Appearing as a noteworthy advance in the fight against obesity, the drug is generating considerable interest . This treatment combines properties of two known GLP-1 receptor agonists, liraglutide, and an unique glucose-dependent hormonal component. Initial patient results have shown significant weight reduction in people with a high BMI , potentia